Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001470831-26-000737
Filing Date
2026-07-29
Accepted
2026-07-29 16:18:24
Documents
1
Period of Report
2026-07-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1785356301.html 4  
1 FORM 4 wk-form4_1785356301.xml 4 4098
  Complete submission text file 0001470831-26-000737.txt   5518
Mailing Address 85 WELLS AVENUE SUITE 210 NEWTON MA 02459
Business Address
Oliger Christy J. (Reporting) CIK: 0001822092 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42271 | Film No.: 261217805

Mailing Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116 617-468-4219
Bicara Therapeutics Inc. (Issuer) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)